Evidence map›Paper›PMID 37477929›Full record

ArticleJAMA2023

Trends in the Use of Mifepristone for Medical Management of Early Pregnancy Loss From 2016 to 2020.

Elise W Boos, Manuel Horta, Ivana Thompson, Stacie B Dusetzina, Ashley A Leech

Open access · greenAbstract read
In one paragraph

Article in JAMA, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Elise W BoosDepartment of Obstetrics and Gynecology, Vanderbilt University Medical Center, Nashville, Tennessee.
Manuel HortaDepartment of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
Ivana ThompsonDepartment of Obstetrics and Gynecology, University of Washington, Seattle.
Stacie B DusetzinaDepartment of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
Ashley A LeechDepartment of Health Policy, Vanderbilt University School of Medicine, Nashville, Tennessee.
Vanderbilt University · USUniversity of Washington · USVanderbilt Health · USVanderbilt University Medical Center · US

Funding

Advancing Treatment Outcomes for Pregnant Women with Opioid Use DisorderK01DA050740 · NIDA · VANDERBILT UNIVERSITY MEDICAL CENTER · PI LEECH, ASHLEY A · 2020 to 2024
$860k
NIDA NIH HHS K01 DA050740
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Abortifacient Agents, NonsteroidalAbortion, SpontaneousMifepristoneFemaleHumansMisoprostolPregnancyAbortifacient Agents, NonsteroidalMifepristoneMisoprostol

Identifiers

PMID37477929
PMCPMC10445186
OpenAlexW4384925978

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.